Read More Pharma Industry News Leyden Labs secures €20m from European Investment Bank: Could this reshape Europe’s pandemic response strategy? Leyden Labs secures €20M EIB funding under HERA Invest to develop intranasal antibody sprays targeting pandemic flu and respiratory threats. byPallavi MadhirajuJune 3, 2025